Andreu Bruguera
Research support
Andreu Bruguera Riera holds a medical degree from the Universitat Autònoma de Barcelona and Hospital Universitari Germans Trias i Pujol (2012). He completed a Master's degree in Public Health and Epidemiology from Universitat Pompeu Fabra in 2015, and his specialization in Preventive Medicine and Public Health at Hospital Universitari de la Vall d’Hebron in 2017. In 2024, he earned his PhD in Medicine and Biomedical Research Methodology and Public Health from the Universitat Autònoma de Barcelona, focusing his thesis on the impact of aging on the incidence of comorbidities in people living with HIV.
Since 2017, Andreu has served as the Coordinator of the PISCIS cohort at the Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Since 2022, he also led the Group on Antiretroviral Treatment Monitoring and Effects of Comorbidities/Aging in HIV Positive Patients at CEEISCAT,
In parallel, since 2022, Andreu is also an Associate Professor in Medicine at the Universitat Autònoma de Barcelona, where he teaches Epidemiology and Preventive Medicine.
In 2025, he joined the Cancer Epidemiology Research Program (PREC) at ICO as epidemiologist working for the Technical Office for Cervical Cancer Screening.
Email: abruguerar
PUBLICACIONS SELECCIONADAS:
• Bruguera A, Nomah DK, Moreno-Fornés S, Martinez E, Negredo E, Tiraboschi J, Navarro J, Domingo P, Fanjul F, Villoslada A, Peraire J, Jaen A, Miró JM, Casabona J, Reyes-Urueña J; the PISCIS Study Group. Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands. AIDS. 2025 Jan 1;39(1):64-74.
• Bruguera A, Egea-Cortés L, Mesías-Gazmuri J, Palacio-Vieira J, Forero CG, Miranda C, Saumoy M, Fernández E, Navarro G, Orti A, Miró JM, Casabona J, Reyes-Urueña J; PISCS Study Group. Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project. HIV Med. 2024 Apr;25(4):424-439
• Bruguera A, Nomah D, Moreno-Fornés S, Díaz Y, Aceitón J, Reyes-Urueña J, Ambrosioni J, Llibre JM, Falcó V, Imaz A, Fanjul F, Navarro G, Pere D, León E, Mera A, Miró JM, Casabona J; PISCIS Cohort Group. Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands. Int J Epidemiol. 2023 Aug 2;52(4):e241-e252.
• Nomah DK, Jamarkattel S, Bruguera A, Moreno-Fornés S, Díaz Y, Alonso L, Aceitón J, Llibre JM, Domingo P, Saumoy M, Homar F, Fanjul F, Navarro J, de la Mora L, Knobel H, Orti A, Martin-Iguacel R, Miró JM, Casabona J, Reyes-Urueña J. Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020. Open Forum Infect Dis. 2024 Mar 8;11(4):ofae132.
• Palacio-Vieira J, Díaz Y, Moreno-Fornés S, Bruguera A, Nomah DK, Llibre JM, Knobel H, Chivite I, Miró JM, Suanzes P, Fanjul F, Navarro G, Macorigh L, Homar Borràs F, Vilaró López I, Orti Llaveria AJ, Casabona J, Imaz A, Reyes-Urueña J; PISCIS Study Group. Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIV. Int J STD AIDS. 2024 Oct;35(12):952-962. doi: 10.1177/09564624241270967. Epub 2024 Aug 15. PMID: 39148144.
• Martín-Iguacel R, Pericas C, Bruguera A, Rosell G, Martínez E, Díaz Y, Alonso L, Nomah DK, Blanco JL, Domingo P, Álvarez-López P, Linares MS, Vilades Laborda C, Mera A, Calzado Isbert S, Johansen IS, Miró JM, Casabona J, Llibre JM; PISCIS Study Group. Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study. Microorganisms. 2023 Nov 3;11(11):2701.
• Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falcó V, Imaz A, Cortés C, Force L, Letang E, Vilaró I, Casabona J, Miro JM; PISCIS study group. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021 Nov;8(11):e701-e710.
• Greenberg L, Ryom L, Neesgaard B, Miró JM, Dahlerup Rasmussen L, Zangerle R, Grabmeier-Pfistershammer K, Günthard HF, Kusejko K, Smith C, Mussini C, Menozzi M, Wit F, Van Der Valk M, d'Arminio Monforte A, De Wit S, Necsoi C, Pelchen-Matthews A, Lundgren J, Peters L, Castagna A, Muccini C, Vehreschild JJ, Pradier C, Bruguera Riera A, Sönnerborg A, Petoumenos K, Garges H, Rogatto F, Dedes N, Bansi-Matharu L, Mocroft A; RESPOND Study Group. Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting. Open Forum Infect Dis. 2022 Jan 19;9(3):ofac029. doi: 10.1093/ofid/ofac029. PMID: 35198646; PMCID: PMC8860165.
• Gil Olivas E, Bruguera A, Eugenio ANE, Nunda JJ, Tchiyanga A, Ekavo FG, Cambali A, Moreno M, Bocanegra García C, Aznar ML, Salvador F, Sánchez-Montalvá A, Molina I. Civil Engineering and Malaria Risk: A Descriptive Study in a Rural Area of Cubal, Angola. Trop Med Infect Dis. 2023 Feb 1;8(2):96. doi: 10.3390/tropicalmed8020096. PMID: 36828512; PMCID: PMC9961019.
• Gimferrer L, Andrés C, Campins M, Codina MG, Rodrigo JA, Melendo S, Martin MC, Fuentes F, Saiz MR, Esperalba J, Bruguera A, Vilca LM, Armadans L, Pumarola T, Antón A. Circulation of a novel human respiratory syncytial virus Group B genotype during the 2014-2015 season in Catalonia (Spain). Clin Microbiol Infect. 2016 Jan;22(1):97.e5-97.e8.